Stereotactic Procedures: Precision Diagnosis and Treatment

Stereotactic procedures represent one of the most significant advances in modern medicine — enabling surgeons, oncologists, and radiologists to target tissue deep inside the body with sub-millimetre accuracy, guided by three-dimensional imaging rather than open surgical exposure. From diagnosing suspicious breast lesions to delivering lethal radiation doses to brain tumors without a single incision, stereotactic technology has fundamentally expanded what is clinically possible.

This guide covers the full spectrum of stereotactic procedures — how they work, when they are used, and what patients can expect from diagnosis through to treatment.

What Are Stereotactic Procedures?

The word stereotactic derives from the Greek for three-dimensional arrangement. In clinical practice, it refers to a family of techniques that use a precise coordinate system — generated from CT, MRI, or mammographic imaging — to localise a target in three-dimensional space and guide instruments or radiation to it with exceptional accuracy. The defining characteristic of all stereotactic procedures is precision: the ability to reach a specific point inside the body — a tumour, a lesion, an abnormal cluster of cells — while minimising damage to surrounding healthy tissue.

This precision is what makes stereotactic approaches preferable to conventional surgery or standard radiation in a growing range of clinical scenarios. Targets that are too deep, too small, or too close to critical structures for safe open surgery become accessible. Radiation doses that would be too toxic if spread across a wide field can be concentrated into a small volume over fewer sessions, dramatically improving the therapeutic ratio.

The Stereotactic Frame

The stereotactic frame is the foundational instrument that made modern stereotactic surgery possible. It is a rigid structure — typically attached to the skull under local anaesthesia — that establishes a fixed three-dimensional coordinate reference relative to the patient's anatomy. Once the frame is in place, imaging is performed and the coordinates of the target are calculated precisely within the frame's geometry, allowing instruments or radiation beams to be directed to that exact point.

Modern frameless stereotactic systems have since emerged, using surface markers, implanted fiducials, or real-time imaging to achieve comparable accuracy without the physical frame. Both approaches remain in clinical use depending on the procedure type, institution, and clinical context.

Stereotactic Neurosurgery and Brain Procedures

Stereotactic neurosurgery encompasses a broad range of diagnostic and therapeutic interventions targeting structures within the brain and skull. The unifying principle is imaging-guided precision — reaching deep cerebral targets safely, without the exposure and risk associated with open craniotomy.

Stereotactic Brain Biopsy

Stereotactic biopsy of the brain is the standard method for obtaining tissue from intracranial lesions that cannot be safely reached through open surgery, or where a tissue diagnosis is needed before committing to a treatment plan. A fine needle is guided to the lesion using frame-based or frameless stereotactic navigation, and one or more tissue cores are extracted for histopathological analysis. Stereotactic brain biopsy is most commonly performed for suspected brain tumors, lymphomas, abscesses, or inflammatory lesions in deep or eloquent brain regions.

The procedure carries significantly lower risk than open craniotomy while delivering diagnostically adequate tissue in the vast majority of cases. It is typically performed under general or local anaesthesia with sedation, and most patients are discharged within twenty-four to forty-eight hours.

Stereotactic EEG

Stereotactic EEG — also known as SEEG or stereotactic electroencephalography — is a minimally invasive technique used in the evaluation and surgical planning of drug-resistant epilepsy. Multiple depth electrodes are implanted into precise brain regions using stereotactic guidance, allowing neurophysiologists to map seizure onset zones and propagation pathways in three dimensions. Unlike traditional subdural grid implantation, stereotactic EEG involves no craniotomy, causes significantly less morbidity, and can sample deep and bilateral structures simultaneously. It has become the preferred intracranial monitoring method at leading epilepsy surgery centres worldwide.

Stereotactic Radiosurgery and Stereotactic Radiotherapy

Stereotactic radiation techniques deliver highly focused beams of ionising radiation to a defined target with submillimetre precision, using multiple convergent beams that individually carry insufficient dose to damage tissue but deposit a lethal concentration at their point of intersection. The distinction between stereotactic radiosurgery and stereotactic radiotherapy is primarily one of fractionation.

Stereotactic Radiosurgery

Stereotactic radiosurgery administers the full radiation dose in a single session using multiple convergent beams that individually carry insufficient energy to damage tissue but deposit a lethal concentration precisely at their point of intersection. Despite the surgical terminology, no incision is made at any point. The most widely used dedicated platform is Gamma Knife, which uses 192 cobalt-60 sources arranged in a hemispherical array to deliver beams that converge with sub-millimetre accuracy on intracranial targets. Gamma Knife has accumulated decades of clinical evidence across thousands of institutions and remains the reference standard for intracranial stereotactic radiosurgery. Linear accelerator-based systems and CyberKnife — a robotic platform capable of treating both intracranial and extracranial targets — offer comparable precision through different technical approaches. Stereotactic radiosurgery is used for:

• Brain tumors, both primary and metastatic
• Acoustic neuromas and other benign intracranial tumours
• Arteriovenous malformations
• Trigeminal neuralgia
• Selected cases of pituitary adenoma

The radiobiological rationale for single-fraction delivery is that certain targets — particularly small, well-defined lesions — can be ablated more effectively with one high dose than with multiple smaller fractions, provided surrounding tissue can be adequately spared.

Stereotactic Radiotherapy

Stereotactic radiotherapy delivers the same precision targeting over multiple fractions — typically two to five sessions — allowing a higher total dose to be administered safely to targets adjacent to critical structures. It is the preferred approach for larger lesions, tumours near the optic apparatus or brainstem, and cases where normal tissue tolerance makes single-fraction delivery inappropriate. Radiation therapy for brain tumors increasingly uses stereotactic radiotherapy as the standard of care for both primary tumours and brain metastases, often replacing or deferring whole-brain radiation and its associated cognitive side effects.

Stereotactic Body Radiation Therapy

Stereotactic body radiation therapy — commonly abbreviated as SBRT, and also referred to as SBRT stereotactic body radiotherapy or stereotactic ablative radiotherapy — extends the same precision fractionation principles to extracranial targets. It delivers ablative doses to tumours in the lung, liver, spine, prostate, pancreas, kidney, and adrenal glands over one to five sessions, exploiting the same convergent beam geometry that makes intracranial stereotactic radiation effective.

Stereotactic body radiation therapy for lung cancer has become one of the most important applications of the technique. In patients with early-stage non-small cell lung cancer who are medically inoperable, SBRT achieves local control rates comparable to surgical resection — with substantially lower procedural risk and no requirement for general anaesthesia. It is now a standard of care recommendation in this patient population across international oncology guidelines. SBRT is also increasingly used for oligometastatic disease — a limited number of metastatic deposits — where ablating individual sites can meaningfully extend progression-free survival.

Stereotactic Breast Procedures

Stereotactic imaging guidance has transformed the diagnosis of breast abnormalities that are visible on mammography but not palpable and not visible on ultrasound — calcification clusters and subtle density changes that require tissue sampling but cannot be targeted by hand.

Stereotactic Breast Biopsy and Stereotactic Core Biopsy

Stereotactic breast biopsy uses mammographic imaging acquired from two angles to calculate the precise three-dimensional coordinates of a lesion within the breast, guiding a biopsy needle to it with accuracy that manual palpation cannot achieve. Stereotactic core biopsy — the most commonly performed variant — uses a hollow needle to extract multiple cylindrical tissue cores for histopathological analysis, typically under local anaesthesia and without surgical incision.

The procedure avoids the need for surgical excision biopsy in the majority of cases, reducing patient morbidity, recovery time, and cost while delivering equivalent diagnostic accuracy. Results guide subsequent clinical decision-making: benign findings can be monitored, atypical findings managed with surgical excision, and malignant findings proceed directly to treatment planning.

Upright Stereotactic Breast Biopsy

Upright stereotactic breast biopsy is performed with the patient seated in an upright position rather than lying prone on a dedicated biopsy table. This approach is particularly valuable for patients who cannot tolerate the prone position, for lesions located in areas of the breast that are difficult to access on a prone table, and in settings where a dedicated prone stereotactic unit is unavailable. Modern upright systems offer comparable accuracy to prone table systems and have expanded access to stereotactic breast biopsy in a wider range of clinical environments.

What to Expect From a Stereotactic Procedure

While the specific experience varies considerably depending on the type of stereotactic procedure, several features are broadly consistent across the category:

• Most stereotactic procedures are minimally invasive, performed under local anaesthesia with or without sedation, and do not require overnight admission
• Pre-procedure imaging — CT, MRI, or mammography depending on the target — is essential and is typically performed on the same day
• The procedure itself is generally well tolerated, with discomfort limited to the anaesthetic injection and mild pressure during needle or electrode placement
• Recovery is significantly faster than open surgery; most patients resume normal activities within one to several days
• Side effects depend on the anatomical target and technique, and are discussed in detail during pre-procedure consultation

Stereotactic radiosurgery and radiotherapy carry their own post-treatment considerations, including a period of radiation response in surrounding tissue that may produce temporary swelling, fatigue, or neurological changes depending on the treatment site.

Stereotactic Procedures at Medical Park Hospitals in Turkey

Medical Park Hospitals offers the full spectrum of stereotactic procedures across neurosurgery, radiation oncology, and breast diagnostics, delivered by multidisciplinary specialist teams using current-generation imaging and treatment platforms. For international patients, Turkey combines JCI-accredited hospital infrastructure with treatment costs substantially below those of equivalent centres in Western Europe or North America — without reduction in technological capability or clinical standard.

Neurosurgical teams at Medical Park perform stereotactic brain biopsy and stereotactic EEG within a comprehensive neuro-oncology and epilepsy surgery programme. For stereotactic radiosurgery, Medical Park operates one of the most extensive Gamma Knife and CyberKnife networks in Turkey, with dedicated units across multiple Istanbul hospital complexes. Medical Park Göztepe Hospital houses a dedicated Gamma Knife Icon centre widely recognised as one of the leading facilities of its kind in the country. Medical Park Bahçelievler Hospital offers both Gamma Knife and CyberKnife M6 within its oncology department, and VM Medical Park Florya Hospital is established as one of Istanbul's top centres for both modalities. Medical Park Istanbul Oncology Hospital and Istinye University Hospital Liv Bahçeşehirfurther extend stereotactic radiosurgery access across the network.

Stereotactic radiotherapy and SBRT services cover the full range of extracranial indications — lung cancer, liver metastases, spinal disease, and oligometastatic presentations — within a multidisciplinary tumour board framework. Breast radiology teams provide stereotactic breast biopsy and stereotactic core biopsy as part of an integrated diagnostic pathway, with same-day results available for international patients coordinating travel around their workup.

All procedures are supported by pre-treatment multidisciplinary review, multilingual patient counselling, and structured follow-up — ensuring clinical precision is matched by clarity and continuity throughout the entire patient journey. For a broader overview of cancer diagnosis and treatment options available across the Medical Park network, visit our comprehensive guide on oncology treatment in Turkey.